Ningxia Zhongke Biotechnology Co (SHSE:600165) Beneish M-Score: 0.69 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
53 GF Score
Price ¥2.43
GF Value ¥2.77
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co Beneish M-Score?

Ningxia Zhongke Biotechnology Co SHSE:600165 +9.95% 53 Beneish M-Score is 0.69 as of Jul. 27, 2026. GuruFocus rates SHSE:600165 with a GF Score™ of 53/100 and a GF Value™ of ¥2.77 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,527 Chemicals companies, Ningxia Zhongke Biotechnology Co ranks worse than 96.4% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 0.69 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Ningxia Zhongke Biotechnology Co's Beneish M-Score or its related term are showing as below:

SHSE:600165' s Beneish M-Score Range Over the Past 10 Years
Min: -209.12   Med: -2.63   Max: 34.39
Current: 0.69

During the past 13 years, the highest Beneish M-Score of Ningxia Zhongke Biotechnology Co was 34.39. The lowest was -209.12. And the median was -2.63.


Ningxia Zhongke Biotechnology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Ningxia Zhongke Biotechnology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningxia Zhongke Biotechnology Co Beneish M-Score Chart

Ningxia Zhongke Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.96 -209.12 -1.77 -3.39 -1.13

Ningxia Zhongke Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.60 -0.74 -0.98 -1.13 0.69

SHSE:600165 vs LIN, SHW, ECL: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, Ningxia Zhongke Biotechnology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ningxia Zhongke Biotechnology Co Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ningxia Zhongke Biotechnology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ningxia Zhongke Biotechnology Co's Beneish M-Score falls into.


SHSE:600165
53GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningxia Zhongke Biotechnology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ningxia Zhongke Biotechnology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.6809+0.528 * 2.1418+0.404 * 0.4985+0.892 * 1.2156+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7907+4.679 * 0.150393-0.327 * 0.1199
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥205.9 Mil.
Revenue was 117.652 + 117.129 + 111.763 + 121.768 = ¥468.3 Mil.
Gross Profit was 9.138 + -6.284 + -27.739 + -27.746 = ¥-52.6 Mil.
Total Current Assets was ¥712.0 Mil.
Total Assets was ¥2,405.6 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,614.3 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥23.6 Mil.
Total Current Liabilities was ¥263.2 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0.0 Mil.
Net Income was -64.316 + 160.602 + -79.979 + -106.924 = ¥-90.6 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -144.512 + -136.918 + -47.99 + -122.98 = ¥-452.4 Mil.
Total Receivables was ¥63.2 Mil.
Revenue was 93.822 + 160.791 + 71.031 + 59.6 = ¥385.2 Mil.
Gross Profit was -26.926 + -66.826 + 11.332 + -10.309 = ¥-92.7 Mil.
Total Current Assets was ¥242.4 Mil.
Total Assets was ¥2,163.6 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,778.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥24.5 Mil.
Total Current Liabilities was ¥1,972.6 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(205.852 / 468.312) / (63.165 / 385.244)
=0.439562 / 0.163961
=2.6809

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-92.729 / 385.244) / (-52.631 / 468.312)
=-0.240702 / -0.112384
=2.1418

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (711.961 + 1614.288) / 2405.588) / (1 - (242.381 + 1778.111) / 2163.637)
=0.032981 / 0.066159
=0.4985

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=468.312 / 385.244
=1.2156

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1778.111)) / (0 / (0 + 1614.288))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(23.571 / 468.312) / (24.523 / 385.244)
=0.050332 / 0.063656
=0.7907

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 263.195) / 2405.588) / ((1.306 + 1972.613) / 2163.637)
=0.10941 / 0.912315
=0.1199

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-90.617 - 0 - -452.4) / 2405.588
=0.150393

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ningxia Zhongke Biotechnology Co has a M-score of 0.69 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.69 mean?
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a Beneish M-Score of 0.69 as of Jul. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. According to the industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #1472 out of 1527 companies in the Chemicals industry, placing it in the top 96.4%.
Is Ningxia Zhongke Biotechnology Co's Beneish M-Score too high?
Ningxia Zhongke Biotechnology Co's current Beneish M-Score is 0.69. Based on the distribution chart, Ningxia Zhongke Biotechnology Co ranks #1472 out of 1527 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's Beneish M-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #1472 out of 1527 companies for Beneish M-Score. This places Ningxia Zhongke Biotechnology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. Ningxia Zhongke Biotechnology Co's current Beneish M-Score is 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥2.77, compared to a current price of ¥2.43 — trading 12.3% below its estimated fair value. The current Beneish M-Score is 0.69. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current Beneish M-Score is 0.69 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be undervalued. The current stock price of ¥2.43 is trading 12.3% below its estimated GF Value™ of ¥2.77. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600165:

  • Beneish M-Score: 0.69
  • GF Value™: ¥2.77 vs. price of ¥2.43 (12.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
53GF Score

Get the complete analysis for SHSE:600165

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.43
Price
¥2.77
GF Value